Objective:
To analyse fibroid vascularisation measured with three-dimensional (3D) power Doppler in relation to absolute fibroid volume change during 12 months of follow up and in relation to fibroid growth rate per year.
Design:
A prospective cohort study was performed between March 2012 and March 2014.
Setting:
Outpatient clinic of the VU medical centre, Amsterdam.
Population Or Sample:
All premenopausal women diagnosed with a maximum of two fibroids with expectant management were consecutively included.
Methods:
Three-dimensional ultrasound including power Doppler was performed at baseline, 3, 6 and 12 months. Volume and vascular parameters were calculated using VOCAL software.
Main Outcome Measures:
The relationship between vascular index (VI) at baseline and fibroid volume over time was analysed using linear mixed model analyses for repeated measurements. Second, the relationship between VI at baseline and fibroid growth rate per year was calculated using linear regression analyses. Analyses were adjusted for possible confounders.
Results:
In all, 66 women (mean age 42 years) completed 12 months of follow up without treatment. Baseline fibroid vascularisation (VI) measured with 3D power Doppler is correlated with fibroid volume at 12 months (P = 0.02 ). An increase of 1% in VI at baseline was associated with a 7.00-cm larger fibroid volume at 12 months. Furthermore, vascularisation was also associated with fibroid growth rate per year (P = 0.04).
Conclusion:
In women with uterine fibroids without therapy, baseline vascularisation (VI) measured with 3D power Doppler is correlated with absolute fibroid volume change at 12 months and with fibroid growth rate per year.
Tweetable Abstract:
Fibroid vascularisation correlates with absolute fibroid volume change and fibroid growth rate per year.
Citing Articles
A Study of Fibroid Vascularization and Vascular Indices With Three-Dimensional Power Doppler and Superb Microvascular Imaging and the Correlation With Heavy Menstrual Bleeding.
Malik N, Ranjan R, Khatri R, Kumari S, Malik V, Singh U
Cureus. 2024; 16(10):e71246.
PMID: 39525203
PMC: 11550482.
DOI: 10.7759/cureus.71246.
Radiomics and quantitative multi-parametric MRI for predicting uterine fibroid growth.
Drukker K, Medved M, Harmath C, Giger M, Madueke-Laveaux O
J Med Imaging (Bellingham). 2024; 11(5):054501.
PMID: 39280239
PMC: 11391479.
DOI: 10.1117/1.JMI.11.5.054501.
Microvascular flow imaging of fibroids: A prospective pilot study.
Frijlingh M, Stoelinga B, de Leeuw R, Hehenkamp W, Twisk J, den Bosch T
Acta Obstet Gynecol Scand. 2024; 103(11):2193-2202.
PMID: 39263938
PMC: 11502429.
DOI: 10.1111/aogs.14914.
Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding.
Wang L, Quan S, Bai E, Yang X
Front Oncol. 2024; 14:1370681.
PMID: 38487719
PMC: 10937355.
DOI: 10.3389/fonc.2024.1370681.
Visualisation of microvascular flow in benign uterine disorders: a pilot study of a new diagnostic technique.
Frijlingh M, de Leeuw R, Juffermans L, Van den Bosch T, Huirne J
Facts Views Vis Obgyn. 2023; 15(2):115-122.
PMID: 37436047
PMC: 10410655.
DOI: 10.52054/FVVO.15.2.072.
A prospective ultrasound study of cigarette smoking and uterine leiomyomata incidence and growth.
Wesselink A, Wegienka G, Coleman C, Geller R, Harmon Q, Upson K
Am J Obstet Gynecol. 2023; 229(2):151.e1-151.e8.
PMID: 37148957
PMC: 10524545.
DOI: 10.1016/j.ajog.2023.04.041.
Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors.
Seidel V, Wernecke K, Bellingkrodt A, Armbrust R, David M
Geburtshilfe Frauenheilkd. 2023; 83(4):446-452.
PMID: 37034415
PMC: 10076097.
DOI: 10.1055/a-1996-2980.
Gonadotropin-Releasing Hormone agonist (GnRH-a) Pretreatment before Hormone Replacement Therapy Does Not Improve Reproductive Outcomes of Frozen-Thawed Embryo Transfer Cycle in Older Patients with Intrauterine Fibroid: A Retrospective Cohort Study.
Sun P, Dong Y, Yu Y, Xu H, Zhu L, Zhang P
J Clin Med. 2023; 12(4).
PMID: 36835936
PMC: 9959616.
DOI: 10.3390/jcm12041401.
Prediction using T2-weighted magnetic resonance imaging-based radiomics of residual uterine myoma regrowth after high-intensity focused ultrasound ablation.
Zhou Y, Zhang J, Chen J, Yang C, Gong C, Li C
Ultrasound Obstet Gynecol. 2022; 60(5):681-692.
PMID: 36054291
PMC: 9828488.
DOI: 10.1002/uog.26053.
How to use power Doppler ultrasound in transvaginal assessment of uterine fibroids.
Frijlingh M, Juffermans L, de Leeuw R, De Bruyn C, Timmerman D, Van den Bosch T
Ultrasound Obstet Gynecol. 2022; 60(2):277-283.
PMID: 35195311
PMC: 9543636.
DOI: 10.1002/uog.24879.
Fibroid vascularisation assessed with 3D Power Doppler as predictor for fibroid related symptoms and quality of life; a pilot study.
Keizer A, Niewenhuis L, Hehenkamp W, Twisk J, Brolmann H, Huirne J
Facts Views Vis Obgyn. 2022; 13(4):387-394.
PMID: 35026100
PMC: 9148716.
DOI: 10.52054/FVVO.13.4.044.
Acute and repeated haemoperitoneum: a challenging case of lymphangioleiomyomatosis with uterine PEComa.
Xholli A, Kratochwila C, Vellone V, Schiaffino M
BMJ Case Rep. 2021; 14(11).
PMID: 34728504
PMC: 8565543.
DOI: 10.1136/bcr-2021-244257.
Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach.
Dolmans M, Cacciottola L, Donnez J
J Clin Med. 2021; 10(19).
PMID: 34640407
PMC: 8509802.
DOI: 10.3390/jcm10194389.
Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird D, Patchel S, Saldana T, Umbach D, Cooper T, Wegienka G
Am J Obstet Gynecol. 2020; 223(3):402.e1-402.e18.
PMID: 32105679
PMC: 8039858.
DOI: 10.1016/j.ajog.2020.02.016.
3D Power Doppler vascular indices as a novel technique in assessing the outcome of minimally invasive techniques in uterine fibroids treatment.
Stepniak A, Czuczwar P
Prz Menopauzalny. 2018; 16(4):118-121.
PMID: 29483852
PMC: 5824680.
DOI: 10.5114/pm.2017.72755.
